Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis (original) (raw)

Nature Medicine volume 30, page 2692 (2024)Cite this article

Subjects

Correction to: Nature Medicine https://doi.org/10.1038/nm.3618, published online 6 July 2014

In the original version of the article, due to a figure preparation error in pseudo-coloring and image selection, the image shown in Fig. 3e was incorrect. An updated Fig. 3e is shown below (Fig. 1).

Fig. 1

figure 1

Corrected Fig. 3e.

Full size image

Author information

Author notes

  1. These authors contributed equally: Feng Mei and Stephen P J Fancy

Authors and Affiliations

  1. Department of Neurology and Program in Neuroscience, University of California, San Francisco, San Francisco, California, USA
    Feng Mei, Stephen P J Fancy, Yun-An A Shen, Edna Miao, Seonok Lee, Sonia R Mayoral, Stephanie A Redmond, Ainhoa Etxeberria, Ari Green, Stephen L Hauser & Jonah R Chan
  2. Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA
    Stephen P J Fancy
  3. Department of Histology and Embryology, Chongqing Key Laboratory of Neurobiology, Third Military Medical University, Chongqing, China
    Jianqin Niu & Lan Xiao
  4. Cambridge Stem Cell Institute and Department of Veterinary Medicine, Wellcome Trust Medical Research Council, University of Cambridge, Cambridge, UK
    Chao Zhao & Robin J M Franklin
  5. Trianja Technologies, Allen, Texas, USA
    Bryan Presley

Authors

  1. Feng Mei
  2. Stephen P J Fancy
  3. Yun-An A Shen
  4. Jianqin Niu
  5. Chao Zhao
  6. Bryan Presley
  7. Edna Miao
  8. Seonok Lee
  9. Sonia R Mayoral
  10. Stephanie A Redmond
  11. Ainhoa Etxeberria
  12. Lan Xiao
  13. Robin J M Franklin
  14. Ari Green
  15. Stephen L Hauser
  16. Jonah R Chan

Corresponding author

Correspondence toJonah R Chan.

Rights and permissions

About this article

Cite this article

Mei, F., Fancy, S.P.J., Shen, YA.A. et al. Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.Nat Med 30, 2692 (2024). https://doi.org/10.1038/s41591-024-03162-9

Download citation